[BDRX] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Dec-2022
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 0.00%
YoY- -99.31%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/17 31/12/16 31/12/15 CAGR
Revenue 42 116 89 88 258 -3,614 526 -27.07%
PBT -1,815 -2,545 -1,358 -2,806 -3,145 11,058 -2,991 -6.04%
Tax 59 248 205 421 311 3,036 389 -20.98%
NP -1,756 -2,298 -1,153 -2,385 -2,835 8,023 -2,603 -4.79%
Tax Rate - - - - - -27.45% - -
Total Cost 1,797 2,413 1,242 2,472 3,093 -11,637 3,128 -6.68%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -4,230.12 -1,989.18 -1,302.82 -2,725.14 -1,098.64 -221.98 -495.24 30.72%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/17 31/12/16 31/12/15 CAGR
EPS -32.97 -185.31 -94.32 0.00 0.00 0.00 0.00 -
EPS Diluted -32.97 -185.31 -94.32 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.